Related Experiment Video

Updated: Jul 26, 2026

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti
08:33

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti

Published on: May 16, 2011

Inadequate protection against yellow fever of children visiting endemic areas

I Potasman1, N Pick, C Stringer

  • 1Infectious Diseases Unit and Travel Clinic, B'nai Zion Medical Centre, Rappaport Faculty of Medicine, Technion, Haifa, Israel.

The American Journal of Tropical Medicine and Hygiene
|January 17, 2002
PubMed

Insights

World Health Organization yellow fever vaccination guidelines are often missed for children traveling to endemic areas. Nearly 20% received the vaccine less than 10 days before departure, highlighting a need for better public awareness.

Area of Science:

  • Travel Medicine
  • Infectious Disease Prevention
  • Public Health

Background:

  • The World Health Organization (WHO) recommends yellow fever vaccination at least 10 days prior to travel to endemic regions.
  • Adherence to these guidelines is crucial for preventing disease transmission in travelers.
  • Understanding vaccination practices in travel clinics is essential for assessing guideline compliance.

Purpose of the Study:

  • To evaluate the adherence to WHO yellow fever vaccination guidelines in pediatric travelers.
  • To assess the timeliness of yellow fever vaccine administration in children traveling to endemic areas.
  • To identify potential gaps in the application of vaccination recommendations in travel medicine settings.

Main Methods:

  • A retrospective study evaluated 98 children (9 months to 15 years) planning travel to yellow fever-endemic areas.
  • Data were collected from two travel clinics located in teaching hospitals in Israel and the United Kingdom.
  • The primary outcome measured was the interval between yellow fever vaccination and departure.

Main Results:

  • 19.4% of children (19 out of 98) received the yellow fever vaccine less than 10 days before their planned travel date.
  • No significant difference in adherence was observed between the two travel clinics.
  • A subset of these children (11) received the vaccine less than 7 days before departure.

Conclusions:

  • WHO guidelines for timely yellow fever vaccination are frequently not followed for pediatric travelers.
  • There is a need for public health initiatives to emphasize the importance of pre-travel vaccination well in advance of departure.
  • Improved patient education and clinic protocols may enhance compliance with yellow fever vaccination recommendations.

More Related Videos

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

Propagation of the Microsporidian Parasite Edhazardia aedis in Aedes aegypti Mosquitoes05:29

Propagation of the Microsporidian Parasite Edhazardia aedis in Aedes aegypti Mosquitoes

Published on: August 13, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...